Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer
Go back to Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer| (NASDAQ: KZIA) | Delayed: 13.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.86 | 52 Week High | $ | |||
| Open | $13.86 | 52 Week Low | $ | |||
| Day High | $13.86 | P/E | N/A | |||
| Day Low | $13.86 | EPS | $ | |||
| Volume | 337,533 | |||||
